PCSK9 mutations found in patients diagnosed with autosomal dominant hypercholesterolemia in the Netherlands

被引：0
|
作者：
Fouchier, SW
Peter, J
Lansberg, PJ
Kastelein, JJ
Defesche, JC
机构：
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Fdn Identificat Persons Inherited Hypercholestero, Amsterdam, Netherlands
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [31] Pharmacodynamics of Alirocumab in Patients With Autosomal Dominant Hypercholesterolemia Associated With PCSK9 Gain-Of-Function or ApoB Loss-Of-Function Mutations: An Open-Label Extension Study
    Krempf, Michel
    Hopkins, Paul N.
    Bruckert, Eric
    Luc, Gerald
    Lee, Shane
    Donahue, Stephen
    CIRCULATION, 2018, 138
  • [32] Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients
    Slimani, Afef
    Jelassi, Awatef
    Jguirim, Imen
    Najah, Mohamed
    Rebhi, Lamia
    Omezzine, Asma
    Maatouk, Faouzi
    Ben Hamda, Khaldoun
    Kacem, Maha
    Rabes, Jean-Pierre
    Abifadel, Marianne
    Boileau, Catherine
    Rouis, Mustapha
    Slimane, Mohamed Naceur
    Varret, Mathilde
    ATHEROSCLEROSIS, 2012, 222 (01) : 158 - 166
  • [33] PCSK9 gene analysis in Portuguese patients with familial hypercholesterolemia
    Alves, A. C.
    Rato, Q.
    Furtado, A.
    Bourbon, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 214 - 215
  • [34] Variations in SREBP2 and PCSK9 genes in autosomal dominant hypercholesterolemic patients lacking pathogenic mutations in LDLR and APOB genes
    Blesa, S.
    Garcia, A. B.
    Martinez, S.
    Gonzalez, V.
    Ascaso, J.
    Carmena, R.
    Real, J. T.
    Chaves, F. J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 135 - 135
  • [35] Effect of PCSK9 Inhibitors on Hemostasis in Patients with Isolated Hypercholesterolemia
    Basiak, Marcin
    Hachula, Marcin
    Kosowski, Michal
    Okopien, Boguslaw
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (09)
  • [36] SCREENING OF PCSK9 GENE IN INDIAN FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS
    Reddy, L. L.
    Ponde, C. K.
    Rajani, R. M.
    Pillai, S.
    Dalal, R. J.
    Vanjani, C. V.
    Dalal, J.
    Ashavaid, T. F.
    ATHEROSCLEROSIS, 2019, 287 : E212 - E212
  • [37] Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia
    Pisciotta, Livia
    Oliva, Claudio Priore
    Cefalu, Angelo Baldassare
    Noto, Davide
    Bellocchio, Antonella
    Fresa, Raffaele
    Cantafora, Alfredo
    Patel, Dilip
    Averna, Maurizio
    Tarugi, Patrizia
    Calandra, Sebastiano
    Bertolini, Stefano
    ATHEROSCLEROSIS, 2006, 186 (02) : 433 - 440
  • [38] PCSK9 inhibition in the management of familial hypercholesterolemia
    Ogura, Masatsune
    JOURNAL OF CARDIOLOGY, 2018, 71 (1-2) : 1 - 7
  • [39] The Role of PCSK9 Inhibitors in the Treatment of Hypercholesterolemia
    Patel, Roshni S.
    Scopelliti, Emily M.
    Olugbile, Oludamilola
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (10) : 1000 - 1018
  • [40] ALIROCUMAB: TARGETING PCSK9 TO TREAT HYPERCHOLESTEROLEMIA
    Pecin, I.
    Reiner, Z.
    DRUGS OF TODAY, 2015, 51 (12) : 681 - 687
12345